Art

J-GLOBAL ID：201002240560788987   Reference number：10A0087933

Botulinum Toxin Type A for Migraine Prophylaxis in the Japanese Population: An Open-Label Prospective Trial

日本人集団における片頭痛予防に対するA型ボツリヌス毒素:非盲検前向き試験

Author (3)： SUZUKI Kosuke (Dep. of Neurology, School of Medicine, Kitasato Univ.) ,  IIZUKA Takahiro (Dep. of Neurology, School of Medicine, Kitasato Univ.) ,  SAKAI Fumihiko (Dep. of Neurology, School of Medicine, Kitasato Univ.)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 46  Issue： 13  Page： 959-963 (J-STAGE)  Publication year： 2007 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human (sociology) ,...
Semi thesaurus term： type A botulinum toxin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0087933&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Reference (16)：

• 1. World Health Organization. World Health Report 2002. Reducing Risks, Promoting Healthy Life. WHO, Geneva, 2002: 194-195.
• 2. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17: 15-22, 1997.
• 3. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123 (6): 669-676, 2000.
• 4. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin. type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40 (6): 445-450, 2000.
• 5. Brin MF, Swope DM, O'Brain C, Aboasi S, Pogoda JM. Botox for migraine: Double-blind, Placebo-controlled, region-specific evaluation. Cephalalgia 20: 421-422, 2000.

Terms in the title (6)： 日本人 ,  集団 ,  片頭痛予防 ,  A型ボツリヌス毒素 ,  盲 ,  試験